KCT0008037
Completed
未知
Development of diagnostic method for colon cancer using mutational analyses of tumor tissues and plasma
EONE-DIAGNOMICS GENOME CENTER0 sites350 target enrollmentTBD
ConditionsNeoplasms
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Neoplasms
- Sponsor
- EONE-DIAGNOMICS GENOME CENTER
- Enrollment
- 350
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients aged 18 years or older (male and female) diagnosed with colorectal cancer
- •2\. Patients whose residual tumor is confirmed to be larger than 1cm in diameter after the removed tumor is used for diagnostic purposes
- •3\. When both cancer tissue and plasma can be collected
- •4\. Sign the consent form
- •5\. Patients who are willing to perform all trial\-related procedures within the clinical trial period
Exclusion Criteria
- •1\. If only biopsy is performed
- •2\. In case of accompanying other carcinoma
- •3\. If the patient does not consent
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
The novel diagnostic method of colorectal cancer by methyl mercaptaThe novel diagnostic method for colorectal cancer: Detection of methyl-mercaptan from flatus.JPRN-UMIN000028256Yokohama City University50
Recruiting
Not Applicable
Molecular diagnositcs of colon cancerKCT0002703MD Healthcare350
Completed
Not Applicable
Clinical trial of colon cancer diagnostic reagent by blood mRNA examination for practical usecolon cancerJPRN-UMIN000018914Kanazawa University200
Completed
Phase 1
Search for new lung cancer biomarkers using 13C-labeled glucoseResectable primary lung cancerprimary lung cancerJPRN-jRCTs051200038Yoshida Masaru6
Recruiting
Not Applicable
Development of cancer immune evaluation toolNeoplasmsKCT0002469Seoul Songdo Hospital500